Management of severe hypertension due to lenvatinib in patients with advanced thymic carcinoma: A case report

RATIONALE: Thymic carcinoma (TC) is a malignant mediastinal tumor, and there are no established treatments for pre-treated patients with advanced TC. Recently, lenvatinib was approved for such patients in Japan, ahead of other countries. Higher dose lenvatinib may be more efficacious than convention...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsumoto, Kinnosuke, Shiroyama, Takayuki, Miyake, Kotaro, Yamamoto, Yuji, Kuge, Tomoki, Yoneda, Midori, Yamamoto, Makoto, Naito, Yujiro, Suga, Yasuhiko, Fukushima, Kiyoharu, Koyama, Shohei, Iwahori, Kota, Hirata, Haruhiko, Nagatomo, Izumi, Takeda, Yoshito, Kumanogoh, Atsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8735743/
https://www.ncbi.nlm.nih.gov/pubmed/35029896
http://dx.doi.org/10.1097/MD.0000000000028476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8735743/
https://www.ncbi.nlm.nih.gov/pubmed/35029896
http://dx.doi.org/10.1097/MD.0000000000028476

Ejemplares similares